scorecardresearchStrides Pharma Science Share Price Live NSE, BSE, Today - Strides Pharma
Mintgenie
Asian Paints2,865.053.50 (0.12%)
Axis Bank1,131.654.30 (0.38%)
Bajaj Finance6,758.00-535.90 (-7.35%)
Bajaj Finserv1,599.80-56.00 (-3.38%)
Bharti Airtel1,328.50-7.45 (-0.56%)
HCL Technologies1,527.1023.45 (1.56%)
HDFC Bank1,513.102.45 (0.16%)
Hindustan Unilever2,245.0014.00 (0.63%)
ICICI Bank1,108.35-4.70 (-0.42%)
ITC439.151.65 (0.38%)
Indusind Bank1,468.20-27.95 (-1.87%)
Infosys1,438.500.10 (0.01%)
Kotak Mahindra Bank1,631.00-12.00 (-0.73%)
Larsen & Toubro3,618.20-32.45 (-0.89%)
Mahindra & Mahindra2,069.00-26.55 (-1.27%)
Maruti Suzuki India12,910.003.90 (0.03%)
NTPC356.35-1.95 (-0.54%)
Nestle India2,522.80-39.90 (-1.56%)
Power Grid Corporation Of India294.901.80 (0.61%)
Reliance Industries2,913.90-4.50 (-0.15%)
State Bank Of India802.50-10.10 (-1.24%)
Sun Pharmaceutical Industries1,502.05-18.50 (-1.22%)
Tata Consultancy Services3,857.205.35 (0.14%)
Tata Motors1,004.553.75 (0.37%)
Tata Steel168.000.40 (0.24%)
Tech Mahindra1,293.50103.40 (8.69%)
Titan Company3,564.00-8.65 (-0.24%)
Ultratech Cement9,664.80-18.80 (-0.19%)
Wipro474.7013.70 (2.97%)

Strides Pharma Science

BSE: 532531 | NSE: STAR | ISIN: INE939A01011 | SECTOR: Biotechnology & Drugs

₹890.20 7.85 (0.89%)

26 Apr 2024, 05:38 (IST)

  • Open

    880.15

  • High

    899.20

  • Low

    880.15

  • Prev Close

    882.35

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    81.81B

  • Volume

    8.22K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    890.05

  • Ask

    891.10
View all metrics

Promoter Pledge Holding - 18.81%

Promoter NameNo of SharesPercentage
ARUN KUMAR PILLAI15,22,8811.65%
PRONOMZ VENTURES LLP1,44,74,63015.74%
KARUNA BUSINESS SOLUTIONS LLP12,18,0501.32%
AMBEMATA SECURITIES74,0000.07%

Company Description

  • Biotechnology & Drugs

  • BSE

    532531

  • NSE

    STAR

  • ISIN

    INE939A01011

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Company Officers

  • Arun Pillai

    Executive Chairperson of the Board, Managing Director

  • Badree Komandur

    Group Chief Financial Officer, Executive Director - Finance

  • Ramaraju Pvs

    Chief Operating Officer

  • Manjula Ramamurthy

    Compliance Officer, Company Secretary

  • Umesh Kale

    Chief Quality Officer